We are live on
!
Find out more
SELLAS Life Sciences
11 hedge funds and large institutions have $3.7M invested in SELLAS Life Sciences in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.06% less ownership
Funds ownership: 0.38% → 0.31% (-0.06%)
27% less capital invested
Capital invested by funds: $5.1M → $3.7M (-$1.4M)
45% less funds holding
Funds holding: 20 → 11 (-9)
90% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 10
Holders
11
Holders Change
-9
Holders Change %
-45%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
10
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
-$98K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
| 2 |
Renaissance Technologies
New York
|
+$138K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$15K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.49K |
| 5 |
Morgan Stanley
New York
|
+$1.88K |
